Victrex (LON:VCT) Share Price Crosses Above 200 Day Moving Average – Should You Sell?

Posted by Sarita Garza on Jan 20th, 2026

Victrex plc (LON:VCT – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 677.45 and traded as high as GBX 705. Victrex shares last traded at GBX 695, with a volume of 230,248 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft lowered their target price on shares of Victrex from GBX 850 to GBX 780 and set a “hold” rating on the stock in a report on Tuesday, December 2nd. Four research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of GBX 804.50.

Check Out Our Latest Research Report on VCT

Victrex Stock Down 0.7%

The firm’s 50-day moving average price is GBX 648.91 and its 200 day moving average price is GBX 677.45. The company has a current ratio of 4.39, a quick ratio of 1.99 and a debt-to-equity ratio of 10.93. The company has a market capitalization of £605.14 million, a price-to-earnings ratio of 21.86, a PEG ratio of 1.92 and a beta of 0.69.

Victrex (LON:VCT – Get Free Report) last announced its quarterly earnings data on Tuesday, December 2nd. The company reported GBX 43.90 earnings per share (EPS) for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. On average, sell-side analysts forecast that Victrex plc will post 73.1078905 EPS for the current fiscal year.

Insider Activity at Victrex

In other Victrex news, insider Ian Melling purchased 3,500 shares of the stock in a transaction dated Wednesday, December 17th. The stock was bought at an average price of GBX 643 per share, with a total value of £22,505. Company insiders own 4.10% of the company’s stock.

Victrex Company Profile

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.